Vaxcyte (PCVX) EBITDA (2019 - 2026)
Vaxcyte's EBITDA was -$298.39 million in Q3 2026, compared with -$239.32 million a year earlier.
Powered by 
Analysis
Vaxcyte (PCVX) EBITDA (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, Vaxcyte's EBITDA was -$1.21 billion through Sep 30, 2026; for FY2025, it came in at -$907.28 million.
- In earlier years, EBITDA was -$562.54 million in FY2024, -$464.89 million in FY2023, -$229.42 million in FY2022 and -$101.87 million in FY2021.
- Quarterly EBITDA has moved between -$342.9 million (Q1 2026) and -$29.39 million (Q4 2021) over five years.
- Per Business Quant data, PCVX's EBITDA in the three quarters before Q3 2026 was -$299.78 million (Q2 2026), -$342.9 million (Q1 2026) and -$266.79 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 7.34 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Vaxcyte | 9.91 Bn | 3.83 Bn | - | -298.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -298.39 Mn |
| Jun 30, 2026 | -299.78 Mn |
| Mar 31, 2026 | -342.90 Mn |
| Dec 31, 2025 | -266.79 Mn |
| Sep 30, 2025 | -239.32 Mn |
| Jun 30, 2025 | -223.34 Mn |
| Mar 31, 2025 | -177.84 Mn |
| Dec 31, 2024 | -159.31 Mn |
| Sep 30, 2024 | -138.14 Mn |
| Jun 30, 2024 | -151.63 Mn |
| Mar 31, 2024 | -113.47 Mn |
| Dec 31, 2023 | -195.79 Mn |
| Sep 30, 2023 | -112.22 Mn |
| Jun 30, 2023 | -86.40 Mn |
| Mar 31, 2023 | -70.48 Mn |
| Dec 31, 2022 | -85.61 Mn |
| Sep 30, 2022 | -57.89 Mn |
| Jun 30, 2022 | -47.28 Mn |
| Mar 31, 2022 | -38.64 Mn |
| Dec 31, 2021 | -29.39 Mn |
API Access
Vaxcyte EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=PCVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "PCVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=PCVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();